Cell and Gene Manufacturing and Logistics

31. Empower Your Bioprocess Journey With Innovative Solutions 4/21/2025

    Empower your upstream bioprocess journey with innovative solutions that optimize process control and automate tasks to bring life-saving treatments to the world.

32. Innovations In Sterile Connectors Transform CGT Bioprocessing 4/21/2025

    Explore advancements in single-use sterile connectors transforming CGT bioprocessing by enhancing fluid handling, reducing contamination, and improving process reliability for next-gen therapies.

33. Vial Adapter Considerations For Cell And Gene Therapy Applications 4/21/2025

    Review features that need to be considered to choose a vial adapter for cell and gene therapy drug products and a case study where vial adapter transfer devices have been used to extract lentiviruses.

34. Antibody-Drug Conjugates: Manufacturing Precision Medicines 4/21/2025

    The monoclonal antibody intermediate is engineered for precise delivery of the linker-payload complex. Discover how rigorous storage measures ensure its quality, which is crucial for successful conjugation and functionality.

35. What Is Causing Limited Bioavailability 4/21/2025

    Discover how this label-free whole-body QMSI combined with plasma LC-MS/MS can help identify the root causes of limited bioavailability and guide smarter optimization strategies early in development.

36. Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers 4/17/2025

    The U.S. tariffs on trading partners bring a whole new set of challenges, but there are tactics and strategies companies can deploy to help offset the cost and operational impacts. 

37. Sterile Gas Filtration And Optimization In Bioprocessing 4/17/2025

    Unlock insights into sterile gas filtration challenges in bioprocessing. Watch this on-demand session to learn optimization strategies for critical applications and improved filter performance.

38. Why You Need A Raw Material Control Strategy 4/17/2025

    You should start with the end goal in mind, but the first draft is almost never the last. These living documents should evolve as your team gains process knowledge.

39. Why Pharma Risk Assessments Should Include 'Working Together Alone' 4/16/2025

    When understood and managed properly, subjectivity becomes a source of creativity. It reveals hidden hazards and unlocks more effective risk controls.

40. Simplify Your Downstream Calculations With Bioprocessing Downstream Calculators 4/16/2025

    Simplify complex biopharma downstream processing tasks using a suite of powerful, web-based calculators designed to streamline workflows and automate intricate mathematical modeling.